SABS: SAB Biotherapeutics Inc Company Profile & Statistics

About

SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.

Info & Links

CEO

Samuel J. Reich

Headquarters

2100 EAST 54TH STREET NORTH
SIOUX FALLS, SD 57104, UNITED STATES

Auditor

EISNERAMPER LLP

Share holders

260

Employees

SAB Biotherapeutics Inc Statistics

Valuation Measures

Market Capitalization²

31.38M

Enterprise Value

25.66M

Enterprise Value/EBITDA(ttm)

-0.55

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

13.54

Price to Book(mrq)

1.02

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-1450.11%

Profit Margin(ttm)

-2703.38%

Return on Equity(ttm)

-94.37%

Return on Invested Capital(ttm)

-87.15%

Return on Assets(ttm)

-67.26%

Income Statement

Revenue(ttm)

1.51M

Revenue Per Share(ttm)

0.16

Gross Profit(ttm)

1.51M

EBITDA(ttm)³

-47.04M

Net Income Available to Common(ttm)

-45.57M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.59

52-Week Change

-62.64%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

9.23M

Dividend Yield

0.00%

Float⁴

6.79M

% Held by Insiders

26.46%

% Held by Institutions

7.82%

Balance Sheet

Total Cash(mrq)

30.40M

Total Cash Per Share(mrq)

3.29

Total Debt(mrq)

3.45M

Total Debt/Equity(mrq)

9.36%

Current Ratio(mrq)

3.69%

Quick Ratio(mrq)

3.69%

Book Value Per Share(mrq)

4.00

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.67

Free Cash Flow(ytd)

-25.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SABS

SAB Biotherapeutics Inc

SAB Biotherapeutics Inc Profile